Andrew J. Storaska
Update: How the U.S. Compares to Europe on Biosimilar Approvals and Products In the Pipeline
Biosimilars Law Bulletin ·
Genentech’s Carter ʼ213 Patent Continues to Draw IPR Challenges
Biosimilars Law Bulletin ·
Update: How the U.S. Compares to Europe on Biosimilar Approvals and Products In the Pipeline
Biosimilars Law Bulletin ·
The Impact of Biosimilars on Global Pharmaceutical Markets
Biosimilars Law Bulletin ·
Update: BsUFA II Clears the House and Awaits Senate Vote
Biosimilars Law Bulletin ·